Related Experiment Video
Updated: Mar 13, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
[Towards new targets in the treatment of hypertension?]
Anne-Laure Faucon1, Anne-Marie Madjalian1, Guillaume Bobrie1
1Unité d'hypertension artérielle, Hôpital Européen Georges Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris Paris, France ; Centre d'investigation clinique (CIC 1418), Hôpital Européen Georges Pompidou, AP-HP, Paris, 20, rue Leblanc, 75015 Paris France ; Université Paris-Descartes, Paris, France.
Insights
Blood pressure targets for antihypertensive therapy are debated. The SPRINT study
Area of Science:
- Cardiology
- Public Health
Background:
- Blood pressure is a key factor in cardiovascular disease risk.
- Antihypertensive therapy targets and applicable populations remain subjects of ongoing scientific debate.
- The 2015 Systolic Blood Pressure Intervention Trial (SPRINT) study has influenced current blood pressure management guidelines.
Purpose of the Study:
- To evaluate the generalizability of the SPRINT study findings to the French population.
- To assess the implications of applying SPRINT-like blood pressure targets in France.
Main Methods:
- Analysis of the SPRINT study results.
- Comparative risk assessment between US and French populations.
- Evaluation of potential medical and economic consequences.
Main Results:
- The SPRINT study results may not be directly applicable to the French population.
- The French population exhibits a lower cardiovascular risk profile compared to the US population studied in SPRINT.
- Direct application of SPRINT targets could lead to significant medical and economic challenges in France.
Conclusions:
- Current blood pressure management guidelines may require adaptation for the French population.
- Lowering blood pressure targets based on SPRINT may not be appropriate or cost-effective for France.
- Further research is needed to establish optimal, population-specific blood pressure targets.
Abstract:
Blood pressure is a major determinant of cardiovascular risk. Blood pressure target to reach with antihypertensive therapy, and the population to whom it should apply, remain debatted. Blood pressure goals established by scientific societies may be revised after the publication of the US multicenter SPRINT study results (Systolic Blood Pressure Intervention Trial) obtained in 2015. Analysis of the generalizability of the SPRINT results shows that they may not be directly applied to the french population which is at lower risk than the US population and would have major medical and economic implications.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Action of Diuretics
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies

